Law360, New York (March 05, 2009, 12:00 AM ET) -- The U.S. Department of Justice is taking a closer look at Medtronic Inc.'s marketing practices, reimbursement counsel and therapy delivery concerning its yet-to-be-approved medical tools aimed at controlling irregular heartbeats.
On Wednesday, Medtronic indicated in a regulatory filing that the U.S. Attorney's Office for the Southern District of Texas had been investigating the company since Feb. 9 regarding various aspects of its cardiac ablation therapy.
“The company is in the process of responding to the requests of the government, and will comply as required with the...
DOJ Eyes Medtronic Cardiac Ablation Marketing
To view the full article, take a free trial now.
